Wuhan Wuyao Pharmaceutical Co.,Ltd

Wuhan Wuhan Pharmaceutical Co., Ltd. is a holding subsidiary invested and established by Yuanda (China) Co., Ltd. (formerly Wuhan pharmaceutical factory), and is a well-known enterprise in the production and operation of characteristic API in China. The company passed the acceptance of "second level enterprise of safety production standardization"; In the same year, it was named "high-tech enterprise" in Hubei Province; The annual sales revenue is RMB 600 million, and the products are exported to more than 40 countries and regions such as Europe and America, with an annual export value of US $50million.

According to the opinions of Wuhan Municipal People's Government on accelerating the relocation and renovation of chemical production enterprises in the Third Ring Road of our city (Wuzheng [2008] No. 50) and the overall plan, Wuhan Wuhan Wuhan Pharmaceutical Co., Ltd. has been relocated to the chemical industry park of Fuchi Town, Yangxin County, Huangshi City, Hubei Province. The company has 820 employees and 500 technical and management staff at or above junior college. The registered capital of the company is RMB 61million, which is a high-tech enterprise engaged in the production and operation of API.

Since its establishment, the company has been adhering to "improving good products and cultivating high-level", and developing from large-scale raw materials such as analgin, metronidazole and chloramphenicol to characteristic raw materials. The main production series are tirofiban hydrochloride, noradrenaline tartrate, adrenaline, enoxacin, methoxyming hydrochloride, hydroxychloroquine sulfate, pinoccine sodium Glipizide and other special raw materials and drug intermediates. Enoxacin is the first class II new drug after the drug law of China was promulgated. Tirofiban hydrochloride is the national "Torch Plan" project, and the products of pinoccine sodium and noradrenaline tartrate are exclusively produced in China. The company is committed to the opportunity of "transfer, transformation and transformation", and the members of production and operation management team are committed to the same spirit and strive to move forward.

The company takes "become a pharmaceutical company respected by Chinese doctors and patients and restores to the society" as its vision, and adheres to the core values of "providing good products and cultivating high level". The products cover API and raw material intermediates. The enterprise follows the development direction of product operation, namely, it adheres to the "Ophthalmology, cardiovascular, antibacterial and anti-inflammatory, antipyretic and analgesic, liver protecting and other special raw materials. As a first-class pharmaceutical enterprise, a responsible, respected pharmaceutical enterprise by doctors and patients, it has become a world-famous supplier of characteristic API. With its deep historical deposit, Wuyao pharmaceutical has been listed as a designated enterprise for first aid drugs and narcotic drugs for national war readiness for a long time. Its products such as dimercaptopropanol have been rated as "conscience medicine" and "reassuring medicine" by the industry.